🗺️ Stakeholder Map Ctrl + Alt + Win (MediSure)
Location: Abuja, Nigeria
A stakeholder map shows all the people, groups, and systems connected to the problem of counterfeit medicines and safe access to genuine drugs.
1. Caretakers
People supporting community wellbeing
These are the individuals directly responsible for patient health and safety.
Pharmacists
- Dispense medicines and need to verify authenticity
- Face reputational risk from fake drugs
- Want tools to protect customers
- Serve as first line of defense
Nurses
- Observe treatment effectiveness
- Detect failed medications
- Report suspicious drug batches
- Care for patients harmed by counterfeits
Doctors
- Prescribe medication
- Want reliable drug supply
- Need prescription enforcement
- Face liability when treatments fail
Community Health Workers
- Educate locals about drug safety
- Identify drug misuse issues
- Connect vulnerable populations to safe sources
- Build health awareness
Mothers and Caregivers
- Responsible for family health decisions
- Most vulnerable to counterfeit drugs
- Make affordability vs. safety tradeoffs
- Primary medicine purchasers
2. Primary Stakeholders
Directly affected or involved
These groups have the most influence on medicine sourcing, distribution, and use.
Patients
- Rely on trustworthy medication
- Cannot verify authenticity
- Face treatment failure and health risks
- Bear the ultimate cost of counterfeits
Local Pharmacies
- Purchase stock from distributors
- Face legitimacy risks
- Lose customer trust from fake drugs
- Need verification tools
Drug Distributors
- Source medicines from manufacturers
- Varying reliability and transparency
- Critical link in supply chain
- Can introduce or prevent counterfeits
Hospitals & Clinics
- Store, prescribe, and dispense medication
- Institutional buyers of large quantities
- Need supply chain transparency
- Responsible for patient outcomes
Street Vendors
- Sell cheap medicines without regulation
- No verification systems
- Serve price-sensitive customers
- Major source of counterfeits
Manufacturers
- Produce drugs
- Want to protect product integrity
- Lose revenue to counterfeits
- Need brand protection tools
3. Secondary Stakeholders
Indirect influence
These groups shape the broader environment and regulations.
NAFDAC (Regulatory Authority)
- Monitors drug quality
- Enforces standards
- Lacks real-time visibility
- Needs better enforcement tools
Health NGOs
- Work on public health campaigns
- Awareness and education
- Advocate for policy changes
- Community trust builders
Insurance Providers / HMOs
- Rely on effective treatments for cost control
- Pay for failed treatments
- Interest in reducing fake drug prevalence
- Potential verification partners
Technology Providers
- Enable digital verification systems
- Provide blockchain infrastructure
- Support QR code systems
- Technical implementation partners
Wholesalers & Market Hubs
- Serve as distribution nodes
- Aggregate supply chains
- Potential counterfeit entry points
- Need transparency tools
4. Emerging Leaders
New voices creating change
These individuals can drive adoption of the solution in the community.
Youth Innovators & Tech Enthusiasts
- Eager to try new digital tools
- Early adopters of blockchain
- Social media influencers
- Spread awareness quickly
Pharmacy Owners with Modern Systems
- Early adopters of digital verification
- Tech-forward businesses
- Influence other pharmacies
- Demonstrate proof of concept
Student Leaders and Health Clubs
- Spread awareness in campuses
- Mobilize youth adoption
- Organize health campaigns
- Future healthcare workers
Online Health Influencers
- Can push “Scan Before You Buy” campaigns
- Build public awareness
- Create social proof
- Educate followers about verification
5. Groups Affected by the Problem
Those who suffer most
Low-Income Families
- Buy cheaper drugs with higher risk of being fake
- Cannot afford verified pharmacies
- Most vulnerable to harm
- Choose affordability over safety
Children & Elderly
- Vulnerable to treatment failure
- Higher health risks from fake drugs
- Dependent on caregivers’ decisions
- Most at risk from weak antibiotics/anti-malarials
Chronic Illness Patients
- Diabetes, hypertension, HIV/AIDS patients
- Rely on consistent drug quality
- Treatment failure has severe consequences
- Cannot afford medication gaps
Rural Migrants & Informal Workers
- Often purchase from roadside vendors
- Limited access to verified pharmacies
- High mobility increases risk
- Low health literacy
Stakeholder Map Summary
The ecosystem around counterfeit medicines involves patients, pharmacies, medical workers, regulators, distributors, manufacturers, and emerging youth leaders, all connected by a shared need for safer, transparent, and verifiable access to genuine medication.
MediSure creates value by:
- Giving patients instant verification
- Providing pharmacists supply chain transparency
- Enabling doctors to enforce prescriptions
- Protecting manufacturers’ reputations
- Supporting regulators with real-time data
- Empowering vulnerable populations with safety tools